SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of HealthCor Catalio Acquisition Corp. (Nasdaq – HCAQ)

BALA CYNWYD – July 8, 2021 /Access Wire/ – Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of HealthCor Catalio Acquisition Corp. (“HealthCor Catalio” or the “Company”) (Nasdaq – HCAQ) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which HealthCor Catalio, a special purpose acquisition company, will combine with Hyperfine, Inc. (“Hyperfine”), creator of the first U.S. Food and Drug Administration cleared portable magnetic resonance imaging, and Liminal Sciences, Inc. (“Liminal”), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain and result in Hyperfine/Liminal becoming a publicly-listed company. Under the terms of the agreement, HealthCor Catalio shareholders will retain ownership of only 21.7% of the combined company.

The investigation concerns whether the HealthCor Catalio Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution of ownership interest in the combined company.

If you own shares of HealthCor Catalio stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or call toll free 855-576-4847.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.